Pediatrix Medical Group, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pediatrix Medical Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q4 2024.
  • Pediatrix Medical Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $30.5M.
  • Pediatrix Medical Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$99.1M, a 64% decline year-over-year.
  • Pediatrix Medical Group, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$99.1M, a 64% decline from 2023.
  • Pediatrix Medical Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$60.4M, a 191% decline from 2022.
  • Pediatrix Medical Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $66.3M, a 49.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$99.1M $30.5M +$155M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-20
Q3 2024 -$254M $19.4M -$1.95M -9.12% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$252M -$153M -$181M -641% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-01
Q1 2024 -$70.6M $4.04M -$10.2M -71.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-01
Q4 2023 -$60.4M -$124M -$154M -519% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-20
Q3 2023 $93.5M $21.4M -$9.34M -30.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 $103M $28.3M +$1.15M +4.22% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-01
Q1 2023 $102M $14.2M +$35.4M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-01
Q4 2022 $66.3M $29.7M -$17.9M -37.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-20
Q3 2022 $84.2M $30.7M -$67K -0.22% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $84.3M $27.1M -$7.88M -22.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 $92.1M -$21.2M -$38.8M -220% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 $131M $47.5M +$112M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $19.2M $30.8M +$71.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$52.7M $35M +$707M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$760M $17.6M +$36.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$796M -$64.3M -$73.6M -789% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 -$723M -$41M +$1.21B +96.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$1.94B -$672M -$664M -8056% Apr 1, 2020 Jun 30, 2020 10-Q 2021-10-28
Q1 2020 -$1.27B -$18.7M +$224M +92.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-10-28
Q4 2019 -$1.5B $9.33M -$50.9M -84.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 -$1.45B -$1.26B -$1.32B -2015% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 -$125M -$8.25M -$87.7M -110% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 -$37.7M -$243M -$306M -483% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $269M $60.2M -$75.9M -55.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 $345M $65.6M -$305K -0.46% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-20
Q2 2018 $345M $79.4M +$15.7M +24.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-20
Q1 2018 $329M $63.4M +$8.74M +16% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-20
Q4 2017 $320M $136M +$58M +74.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 $262M $65.9M -$30.6M -31.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-14
Q2 2017 $293M $63.7M -$18.7M -22.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-14
Q1 2017 $312M $54.7M -$13.2M -19.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-14
Q4 2016 $325M $78.1M -$14.6M -15.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-14
Q3 2016 $340M $96.5M +$5.73M +6.31% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-14
Q2 2016 $334M $82.4M -$1.7M -2.02% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-14
Q1 2016 $336M $67.9M -$808K -1.18% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-14
Q4 2015 $336M $92.7M +$4.3M +4.87% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-10
Q3 2015 $332M $90.8M +$4.57M +5.31% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-10
Q2 2015 $327M $84.1M +$5.11M +6.47% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-10
Q1 2015 $322M $68.7M +$5.05M +7.93% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-10
Q4 2014 $317M $88.4M +$9.42M +11.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-11
Q3 2014 $308M $86.2M +$9.25M +12% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-11
Q2 2014 $299M $79M +$9.8M +14.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-11
Q1 2014 $289M $63.7M +$8.29M +15% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-11
Q4 2013 $281M $79M +$12.9M +19.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-09
Q3 2013 $268M $77M +$11M +16.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-09
Q2 2013 $257M $69.2M +$8.67M +14.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-09
Q1 2013 $248M $55.4M +$7.02M +14.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-09
Q4 2012 $241M $66.1M +$7.74M +13.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-12
Q3 2012 $233M $65.9M +$7.67M +13.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-12
Q2 2012 $225M $60.5M +$4.6M +8.23% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-12
Q1 2012 $221M $48.4M +$2.89M +6.37% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-12
Q4 2011 $218M $58.4M +$4.56M +8.47% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $213M $58.2M -$3.03M -4.94% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 $216M $55.9M +$6.58M +13.3% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 $210M $45.5M +$7.19M +18.8% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q4 2010 $203M $53.8M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $61.3M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $49.4M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $38.3M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.